ATS Foundation 2015-2016 Research Awardees Receive Over $1MFebruary 1, 2016 at 5:06 pm
The ATS Foundation is pleased to announce the grant and award recipients for the 2015-2016 grant cycle. Twenty-one new research awards plus four Methods in Epidemiologic, Clinical and Operations Research (MECOR) grants totaling $1.1 million will support research in pulmonary, critical care, and sleep medicine. These awards provide crucial support for early-stage investigators from around the world.
The 2015-2016 grant cycle saw a greater than 80 percent increase in letters of intent compared to last year’s cycle. ATS Scientific Advisory Committee Chair Eric S. White, MD, attributes this increase to expanded efforts to publicize the ATS Foundation Research Program and extending the letters of intent deadline.. Dr. White looks forward to further publicizing the Research Program during ATS 2016.
After the SAC review of grant applications, the ATS Board of Directors recommended that funds be allocated for six unrestricted grants. The recommendation included funding one grant in each of the three ATS pillars of pulmonary, critical care, and sleep medicine. To ensure scientific equity, the remaining three grants were to be awarded to the next highest scored projects in any of the pillars. Three Recognition Awards for Outstanding Early Career Investigators were presented to researchers whose National Institutes of Health (or international equivalent) applications came close to, but did not meet, the government payline.
For disease-specific grants, the ATS Foundation pooled its funds with nonprofit and industry partners. The targeted research areas reflect the partnering organization’s research goals. MECOR grants were offered to alumni of the ATS MECOR program, which provides epidemiological and research methods training to investigators to strengthen capacity and leadership in developing countries.
Through the Grants-for-Hire Program, ATS contracts with organizations to provide grant administrative services, including scientific review. In return, the ATS Foundation receives a fee that allows it to maximize the number of research grants awarded each year.
“The ATS Foundation Research Program has an outstanding return on investment, awarding more than $11 million to 183 researchers who have gone on to secure $143 million in major funding,” says James F. Donohue, MD, chair of the ATS Foundation. He adds, “Thanks to the enthusiastic support of ATS leaders and the overall ATS community, the Foundation will be able to support the career development of outstanding young investigators at a vulnerable time in their careers.”
The ATS Foundation would also like to thank the research program partners that are co-funding a grant for 2015-2016: Alliance for Academic Internal Medicine and the Association of Specialty Professors, Boehringer Ingelheim Pharmaceuticals, Inc., Breathe California of Los Angeles, Hermansky-Pudlak Syndrome Network, Pulmonary Fibrosis Foundation, Pulmonary Hypertension Association, and Scleroderma Foundation.
View a complete list of 2015-2016 Research Awardees through the ATS Foundation Research Program.
The 2016-2017 ATS Foundation Research Program letters of intent period opens in early April. For more details, please contact Erin Marie Nebel, senior manager of the ATS Foundation Research Program.